Frequency of germline patghogenic mutation in breast cancer patients at high risk hereditary cancer.

被引:1
|
作者
Shin, Hee-Chul
Han, Wonshik
Lee, Han-Byoel
Moon, Hyeong-Gon
Lee, Eunshin
Noh, Dong Young
机构
[1] Chung Ang Univ Hosp, Dept Surg, Seoul, South Korea
[2] Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Seoul, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Dept Surg, Coll Med, Seoul, South Korea
关键词
D O I
10.1200/JCO.2017.35.15_suppl.e13110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13110
引用
收藏
页数:5
相关论文
共 50 条
  • [21] A PALB2 germline mutation associated with hereditary breast cancer in Italy
    Papi, Laura
    Putignano, Anna Laura
    Congregati, Caterina
    Piaceri, Irene
    Zanna, Ines
    Sera, Francesco
    Morrone, Doralba
    Genuardi, Maurizio
    Palli, Domenico
    [J]. FAMILIAL CANCER, 2010, 9 (02) : 181 - 185
  • [22] MRI surveillance downstages invasive cancer (IC) to DCIS in women at high risk for hereditary breast cancer.
    Warner, E
    Causer, PA
    Hill, KA
    Ramsay, E
    Jong, RA
    Wong, JW
    Wright, FC
    Detzler, G
    Glazier, J
    Murray, C
    Muldoon, J
    Messner, SJ
    Eisen, A
    Rosen, B
    Verity, L
    Chung, A
    Yaffe, MJ
    Narod, SA
    Plewes, DB
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S205 - S205
  • [23] Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer
    Mike M. Moradian
    Davit T. Babikyan
    Sione Markarian
    Jonny G. Petrosyan
    Nare Avanesian
    Tereza Arutunyan
    Tamara F. Sarkisian
    [J]. Human Genome Variation, 8
  • [24] Germline RECQL mutations in high risk Chinese breast cancer patients
    Kwong, Ava
    Shin, Vivian Y.
    Cheuk, Isabella W. Y.
    Chen, Jiawei
    Au, Chun H.
    Ho, Dona N.
    Chan, Tsun L.
    Ma, Edmond S. K.
    Akbari, Mohammad R.
    Narod, Steven A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (02) : 211 - 215
  • [25] Germline RECQL mutations in high risk Chinese breast cancer patients
    Ava Kwong
    Vivian Y. Shin
    Isabella W. Y. Cheuk
    Jiawei Chen
    Chun H. Au
    Dona N. Ho
    Tsun L. Chan
    Edmond S. K. Ma
    Mohammad R. Akbari
    Steven A. Narod
    [J]. Breast Cancer Research and Treatment, 2016, 157 : 211 - 215
  • [26] Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer
    Moradian, Mike M.
    Babikyan, Davit T.
    Markarian, Sione
    Petrosyan, Jonny G.
    Avanesian, Nare
    Arutunyan, Tereza
    Sarkisian, Tamara F.
    [J]. HUMAN GENOME VARIATION, 2021, 8 (01)
  • [27] High-throughput germline mutation screening for hereditary breast cancer in southern Chinese patients by massively parallel DNA sequencing
    Kwong, A.
    Au, C. H.
    Law, F. B.
    Ho, D. N.
    Ip, B. K.
    Wong, A. T.
    Shin, V. Y.
    Chan, T. L.
    Ma, E. S.
    [J]. CANCER RESEARCH, 2013, 73
  • [28] Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genes
    Tian, Wenjuan
    Bi, Rui
    Ren, Yulan
    He, Hongsheng
    Shi, Shanfu
    Shan, Boer
    Yang, Wentao
    Wang, Qing
    Wang, Huaying
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (05) : 1290 - 1298
  • [29] High-Throughput Germline Mutation Screening for Hereditary Breast Cancer in Southern Chinese Patients by Massively Parallel DNA Sequencing
    Au, C.
    Law, F. B.
    Ho, D. N.
    Ip, B.
    Wong, A. T.
    Chan, T.
    Kwong, A.
    Ma, E. S.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 846 - 846
  • [30] Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
    Kwong, Ava
    Shin, Vivian Yvonne
    Ho, Cecilia Y. S.
    Au, Chun Hang
    Slavin, Thomas P.
    Weitzel, Jeffrey N.
    Chan, Tsun-Leung
    Ma, Edmond S. K.
    [J]. BMC CANCER, 2020, 20 (01)